NO20071231L - Nye anvendelser av 2-fenyl-substituerte imidazotriazinonderivater - Google Patents

Nye anvendelser av 2-fenyl-substituerte imidazotriazinonderivater

Info

Publication number: NO20071231L
Authority: NO; Norway
Prior art keywords: phenyl; substituted; derivatives; new applications; pathological conditions
Prior art date: 2004-08-06

Application number

NO20071231A

Other languages

English (en)

Norwegian (no)

Inventor

Helmut Haning

Original Assignee

Bayer Healthcare Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-08-06

Filing date

2007-03-06

Publication date

2007-05-03

2007-03-06 Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag

2007-05-03 Publication of NO20071231L publication Critical patent/NO20071231L/no

Links

-1 2-phenyl-substituted imidazotriazine Chemical class 0.000 title 1
230000001575 pathological effect Effects 0.000 abstract 2
ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 abstract 1
208000018522 Gastrointestinal disease Diseases 0.000 abstract 1
208000007201 Myocardial reperfusion injury Diseases 0.000 abstract 1
229940123333 Phosphodiesterase 5 inhibitor Drugs 0.000 abstract 1
208000001647 Renal Insufficiency Diseases 0.000 abstract 1
208000027418 Wounds and injury Diseases 0.000 abstract 1
206010000891 acute myocardial infarction Diseases 0.000 abstract 1
230000006378 damage Effects 0.000 abstract 1
206010012601 diabetes mellitus Diseases 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
210000004996 female reproductive system Anatomy 0.000 abstract 1
208000014674 injury Diseases 0.000 abstract 1
201000006370 kidney failure Diseases 0.000 abstract 1
210000004995 male reproductive system Anatomy 0.000 abstract 1
239000002590 phosphodiesterase V inhibitor Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Endocrinology (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Reproductive Health (AREA)
Physical Education & Sports Medicine (AREA)
Pain & Pain Management (AREA)
Hematology (AREA)
Rheumatology (AREA)
Gynecology & Obstetrics (AREA)
Urology & Nephrology (AREA)
Orthopedic Medicine & Surgery (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Psychiatry (AREA)
Pregnancy & Childbirth (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Obesity (AREA)
Ophthalmology & Optometry (AREA)
Hospice & Palliative Care (AREA)
Emergency Medicine (AREA)
Gastroenterology & Hepatology (AREA)

NO20071231A 2004-08-06 2007-03-06 Nye anvendelser av 2-fenyl-substituerte imidazotriazinonderivater NO20071231L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE102004038328A DE102004038328A1 (de)	2004-08-06	2004-08-06	Neue Verwendungen von 2-Phenyl-substituierten Imidazotriazinon-Derivaten
PCT/EP2005/008057 WO2006015715A1 (de)	2004-08-06	2005-07-23	Neue verwendungen von 2-phenyl-substituierten imidazotriazinon-derivaten

Publications (1)

Publication Number	Publication Date
NO20071231L true NO20071231L (no)	2007-05-03

Family

ID=34979785

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20071231A NO20071231L (no)	2004-08-06	2007-03-06	Nye anvendelser av 2-fenyl-substituerte imidazotriazinonderivater

Country Status (16)

Country	Link
US (1)	US20070299088A1 (es)
EP (1)	EP1776120A1 (es)
JP (1)	JP2008509101A (es)
KR (1)	KR20070041613A (es)
CN (1)	CN101035539A (es)
AU (1)	AU2005270446A1 (es)
BR (1)	BRPI0514123A (es)
CA (1)	CA2575907A1 (es)
DE (1)	DE102004038328A1 (es)
EC (1)	ECSP077224A (es)
IL (1)	IL181164A0 (es)
MA (1)	MA28811B1 (es)
MX (1)	MX2007001275A (es)
NO (1)	NO20071231L (es)
RU (1)	RU2007108078A (es)
WO (1)	WO2006015715A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2548759T3 (es)	2006-08-24	2015-10-20	Surface Logix, Inc.	Compuestos farmacocinéticamente mejorados
CN102245608A (zh) *	2008-10-08	2011-11-16	百时美施贵宝公司	吡咯并三嗪酮黑色素浓集激素受体-1拮抗剂
ES2549979T3 (es) *	2010-05-26	2015-11-03	Adverio Pharma Gmbh	El uso de estimuladores de la sGC, activadores de la sGC, solos y en combinaciones con inhibidores de la PDE5 para el tratamiento de esclerosis sistémica (EcS)
US8465413B2 (en)	2010-11-25	2013-06-18	Coloplast A/S	Method of treating Peyronie's disease
JP5543039B2 (ja) *	2011-02-23	2014-07-09	ファイザー・インク	神経障害治療のためのイミダゾ［５，１−ｆ］［１，２，４］トリアジン
RU2497203C2 (ru) *	2012-02-13	2013-10-27	Государственное бюджетное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации	Способ фармакологической коррекции ишемии скелетной мышцы силденафилом, в том числе при l-name-индуцированном дефиците оксида азота

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3195210A (en) *	1960-11-02	1965-07-20	L & L Mfg Inc	Process and apparatus for controlling shrinkage in tubular fabrics
US4152700A (en) *	1976-03-01	1979-05-01	Westinghouse Electric Corp.	Radar extractor having means for estimating target location with a range cell
US4235838A (en) *	1978-08-09	1980-11-25	Petrolite Corporation	Use of benzazoles as corrosion inhibitors
DE19812462A1 (de) *	1998-03-23	1999-09-30	Bayer Ag	2-[2-Ethoxy-5(4-ethyl-piperazin-1-sulfonyl) -phenyl]-5-methyl-7-prophyl-3H-imidazo[5,1-f][1,2,4]triazin-4-on Dihydrochlorid
CA2323008C (en) *	1999-10-11	2005-07-12	Pfizer Inc.	Pharmaceutically active compounds
EP1244673A2 (de) *	1999-12-24	2002-10-02	Bayer Aktiengesellschaft	Imidazo[1,3,5]triazinone und ihre verwendung
AU2002314044B2 (en) *	2001-05-09	2006-09-21	Bayer Healthcare Ag	Novel use of 2-phenyl-substituted imidazotriazinones
DE10135815A1 (de) *	2001-07-23	2003-02-06	Bayer Ag	Verwendung von 2-Alkoxyphenyl-substituierten Imidazotriazinonen
WO2004037183A2 (en) *	2002-10-22	2004-05-06	Harbor-Ucla Research And Education Institute	Phosphodiester inhibitors and nitric oxide modulators for treating peyronie’s disease, arteriosclerosis and other fibrotic diseases
WO2004069167A2 (en) *	2003-01-31	2004-08-19	Nastech Pharmaceutical Company Inc.	Method and compositions for treating male infertility
DE10325813B4 (de) *	2003-06-06	2007-12-20	Universitätsklinikum Freiburg	Prophylaxe und/oder Therapie bei der portalen Hypertonie

2004
- 2004-08-06 DE DE102004038328A patent/DE102004038328A1/de not_active Withdrawn
2005
- 2005-07-23 AU AU2005270446A patent/AU2005270446A1/en not_active Abandoned
- 2005-07-23 EP EP05764196A patent/EP1776120A1/de not_active Withdrawn
- 2005-07-23 CN CNA2005800340233A patent/CN101035539A/zh active Pending
- 2005-07-23 US US11/659,624 patent/US20070299088A1/en not_active Abandoned
- 2005-07-23 KR KR1020077005245A patent/KR20070041613A/ko not_active Withdrawn
- 2005-07-23 WO PCT/EP2005/008057 patent/WO2006015715A1/de not_active Ceased
- 2005-07-23 MX MX2007001275A patent/MX2007001275A/es not_active Application Discontinuation
- 2005-07-23 RU RU2007108078/15A patent/RU2007108078A/ru unknown
- 2005-07-23 CA CA002575907A patent/CA2575907A1/en not_active Abandoned
- 2005-07-23 BR BRPI0514123-0A patent/BRPI0514123A/pt not_active Application Discontinuation
- 2005-07-23 JP JP2007524224A patent/JP2008509101A/ja active Pending
2007
- 2007-02-05 IL IL181164A patent/IL181164A0/en unknown
- 2007-02-05 EC EC2007007224A patent/ECSP077224A/es unknown
- 2007-02-21 MA MA29696A patent/MA28811B1/fr unknown
- 2007-03-06 NO NO20071231A patent/NO20071231L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
IL181164A0 (en)	2007-07-04
MA28811B1 (fr)	2007-08-01
BRPI0514123A (pt)	2008-05-27
JP2008509101A (ja)	2008-03-27
WO2006015715A1 (de)	2006-02-16
RU2007108078A (ru)	2008-09-20
CN101035539A (zh)	2007-09-12
DE102004038328A1 (de)	2006-03-16
AU2005270446A1 (en)	2006-02-16
KR20070041613A (ko)	2007-04-18
US20070299088A1 (en)	2007-12-27
MX2007001275A (es)	2009-02-12
EP1776120A1 (de)	2007-04-25
ECSP077224A (es)	2007-03-29
CA2575907A1 (en)	2006-02-16

Legal Events

Date	Code	Title	Description
2009-02-23	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
TW200728305A (en)	2007-08-01	Spiropiperidine beta-sectetase inhibitors for the treatment of alzheimer's disease
WO2006099379A3 (en)	2007-06-14	Benzazole derivatives, compositions, and methods of use as b-secretase inhibitors
WO2007084391A3 (en)	2008-03-20	Thiazole compounds as protein kinase b ( pkb) inhibitors
WO2009155001A3 (en)	2010-02-25	Wnt protein signalling inhibitors
WO2008054698A3 (en)	2008-06-19	Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
WO2010059004A3 (ko)	2010-09-10	스네일-p53 간의 결합을 저해하는 화합물 및 이를 유효성분으로 함유하는 암질환 치료제
EA201270666A1 (ru)	2012-12-28	Соединения и фармацевтические композиции для снижения уровня мочевой кислоты
MX2010006203A (es)	2010-06-25	Derivados de pirazol y uso de los mismos como inhibidores de cinasas dependientes de ciclina.
IL182218A0 (en)	2007-09-20	Preparation and use of biphenyl-4-yl-carbonylamino and derivatives for the treatment of obesity
MX2007005590A (es)	2007-05-24	Compuestos del inhibidor glicogeno fosforilasa y sus composiciones farmaceuticas.
EA200901212A1 (ru)	2010-04-30	3-имидазолилиндолы, предназначенные для лечения пролиферативных заболеваний
WO2005090333A8 (en)	2006-08-24	3-‘4-heterocyclyl -1,2,3,-triazol-1-yl!-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases
WO2009011880A3 (en)	2009-04-02	Heterocyclic modulators of pkb
WO2011011330A3 (en)	2011-05-26	Inhibitors of d-amino acid oxidase
WO2009067493A3 (en)	2009-09-17	1,3,5 tri-subtituted benzenes for treatment of alzheimer's disease and other disorders
EA200970190A1 (ru)	2009-12-30	Соединения индола
EA200800763A1 (ru)	2008-08-29	Терапевтические композиции, содержащие гиалуроновую кислоту и терапевтические антитела, а также способы лечения
NO20064325L (no)	2006-11-22	Heteroarylaminopyrazolderivativer nyttige for behandling av diabetes
ATE507827T1 (de)	2011-05-15	Behandlung pervasiver entwicklungsstörungen
WO2007002836A3 (en)	2008-09-12	Methods and compositions for the prevention and treatment of kidney disease
NO20065079L (no)	2006-11-03	Materialer og metoder for behandling av koaguleringssykdommer
WO2007132292A3 (en)	2008-06-12	Therapy for alzheimer's disease
WO2007133772A3 (en)	2008-11-20	Cdki pathway inhibitors as selective inhibitors of tumor cell growth
WO2007076087A3 (en)	2007-11-08	3-aryl-substituted quinazolones, and uses thereof
WO2006108679A3 (en)	2007-02-22	Substances and pharmaceutical compositions for the inhibition of glyoxalases and their use to combat cancer